This work elucidates a central epitranscriptomic mechanism controlling T helper cell fate and humoral immunity, and nominates NAT10 as a potential therapeutic target for TFH-driven diseases.
Abstract
Chemical modifications of RNA, such as N4-acetylcytidine (ac⁴C), fine-tune gene expression, but their roles in cell fate determination within the immune system remain poorly understood. Here, we identify the RNA cytidine acetyltransferase NAT10 as a pivotal regulator of T follicular helper (TFH) cell differentiation and the germinal centre response. T cell-specific ablation of Nat10 in mice severely impaired TFH cell development, germinal centre formation, and antibody production following viral infection. Integrated epitranscriptomic and transcriptional profiling revealed that NAT10 deposits ac⁴C modifications on a cohort of mRNAs critical for immune function. We pinpointed the transcription factor TOX2 as a key downstream target, showing that ac⁴C modification within its mRNA coding sequence enhances both transcript stability and translation efficiency, thereby promoting TOX2 protein expression. Enforced TOX2 expression fully rescued the TFH differentiation defect in NAT10-deficient cells. This NAT10-ac⁴C-TOX2 axis is conserved in humans, where its activity correlates with the magnitude of vaccine-elicited TFH responses. Furthermore, we identified R428 as a potent NAT10 inhibitor and demonstrated that its administration could suppress pathogenic TFH responses and alleviate symptoms in a mouse model of allergic asthma. Our work elucidates a central epitranscriptomic mechanism controlling T helper cell fate and humoral immunity, and nominates NAT10 as a potential therapeutic target for TFH-driven diseases.
This study provides the first in vivo evidence that Nat10-mediated ac4C modification sustains macrophage proliferation and attenuates colitis progression by stabilizing Mcm2 mRNA.
Jin-Song Wang, Tao Liu, Jia-Cheng Zhao et al.· Science China Life Sciences· 0 citations
Uveitis, a leading cause of blindness, is driven by dysregulated immune responses, particularly autoreactive T cells. Despite advances in understanding its pathogenesis, key regulatory mechanisms remain elusive. Here, we integrate the cleavage under targets and tagmentation (CUT&Tag) and single-cell RNA sequencing (scR...
He Li, Lei Zhu, Zhao-Huai Li et al.· Science Advances· 0 citations
This work unveils a noncanonical axis in which HMGCS1 sustains ER stress to license pTH17 differentiation during autoimmune responses, and thereby unveils a noncanonical axis in which pTH17 immunity and mitigates autoimmune disease in vivo are revealed.
Jie Sun, Ya-Li Lei, Huan-Huan Yang et al.· Science Advances· 0 citations
Inflammatory disease is sustained not only by immune activation but also by the failure of activated cells to terminate effector programs and return tissues to homeostasis. This review evaluates N6-methyladenosine (m6A) as a post-transcriptional regulator of that persistence. Rather than cataloguing diseases or classif...
Yi-Zhang Zhu, Shiye Yang, Lei Qin et al.· Frontiers in Immunology· 0 citations
The STING-ZBP1 signaling cascade is established as a central regulator of macrophage PANoptosis during atherogenesis and a previously unrecognized mechanism linking innate immune signaling to inflammatory cell death in atherosclerosis is uncovered, highlighting this pathway as a promising therapeutic target for atheros...
Hong Zhou, Yue-Qing Han, Danmei Liu et al.· Cell Death & Disease· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.